» Articles » PMID: 27445568

Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 2016 Jul 23
PMID 27445568
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background. Cystic fibrosis (CF) care that is delivered through dedicated, multidisciplinary CF clinics is believed to be partly responsible for improvements in the length and quality of life of persons with CF. We hypothesized patients living farthest from a CF clinic would be seen less frequently than recommended, which would result in reduced access to guideline-recommended care and poorer health outcomes. Methods. We performed a retrospective chart review of 168 patients who accessed CF care primarily through the St. Paul's Hospital Adult CF Clinic. Subjects were stratified into four geographical groups according to the estimated one-way travel time by automobile from their home address to the clinic (<45 mins, 45-150 mins, 150-360 mins, and >360 mins). Results. There were no significant differences in pulmonary function, nutritional status, CF-related complications, or access to guideline-recommended CF pulmonary therapies between the four groups. Compared to the reference (<45 mins) group, subjects in the two farthest groups (>150 mins) were less likely to be seen in the clinic quarterly as recommended by current CF care guidelines (p = 0.002). Those in the farthest group (>360 mins) were at risk for more rapid decline in lung function compared to the reference group (FEV1% predicted annual change: -3.1%/year [95% CI -5.1 to -1.1] versus -0.9%/year [95% CI -1.6 to 0.1], resp., p = 0.04). Conclusions. Access to CF care is a challenge for individuals who live outside Metro Vancouver and has health policy implications. Further initiatives should be undertaken to ensure equitable care for people living with CF.

Citing Articles

Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis.

Oates G, Schechter M Clin Chest Med. 2023; 44(3):555-573.

PMID: 37517835 PMC: 10458995. DOI: 10.1016/j.ccm.2023.03.011.


Built environment factors predictive of early rapid lung function decline in cystic fibrosis.

Gecili E, Brokamp C, Rasnick E, Afonso P, Andrinopoulou E, Dexheimer J Pediatr Pulmonol. 2023; 58(5):1501-1513.

PMID: 36775890 PMC: 10121820. DOI: 10.1002/ppul.26352.


Data driven decision making to characterize clinical personas of parents of children with cystic fibrosis: a mixed methods study.

Szczesniak R, Pestian T, Duan L, Li D, Stamper S, Ferrara B BMC Pulm Med. 2020; 20(1):174.

PMID: 32552880 PMC: 7301999. DOI: 10.1186/s12890-020-01202-x.


Influences of environmental exposures on individuals living with cystic fibrosis.

Szczesniak R, Rice J, Brokamp C, Ryan P, Pestian T, Ni Y Expert Rev Respir Med. 2020; 14(7):737-748.

PMID: 32264725 PMC: 7424635. DOI: 10.1080/17476348.2020.1753507.


The future of cystic fibrosis care: a global perspective.

Bell S, Mall M, Gutierrez H, Macek M, Madge S, Davies J Lancet Respir Med. 2019; 8(1):65-124.

PMID: 31570318 PMC: 8862661. DOI: 10.1016/S2213-2600(19)30337-6.


References
1.
Lechtzin N, West N, Allgood S, Wilhelm E, Khan U, Mayer-Hamblett N . Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial. Contemp Clin Trials. 2013; 36(2):460-9. PMC: 3844027. DOI: 10.1016/j.cct.2013.09.004. View

2.
Buzzetti R, Salvatore D, Baldo E, Forneris M, Lucidi V, Manunza D . An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros. 2009; 8(4):229-37. DOI: 10.1016/j.jcf.2009.04.001. View

3.
Quon B, Psoter K, Mayer-Hamblett N, Aitken M, Li C, Goss C . Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med. 2012; 186(10):1008-13. PMC: 3530210. DOI: 10.1164/rccm.201205-0949OC. View

4.
Dupuis A, Hamilton D, Cole D, Corey M . Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing. J Pediatr. 2005; 147(3):312-5. DOI: 10.1016/j.jpeds.2005.06.043. View

5.
Mahadeva R, Webb K, Westerbeek R, Carroll N, Dodd M, Bilton D . Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998; 316(7147):1771-5. PMC: 28574. DOI: 10.1136/bmj.316.7147.1771. View